Weili Zhang

10PUBLICATIONS
20CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Aug 27, 2026
Preclinical Pharmacological Evaluation of Sacituzumab Govitecan (IMMU-132) in TROP2-Positive Colorectal Liver Metastasis Models.

|Mar 05, 2026
PKM2 Lactylation Promotes Colorectal Cancer Vasculogenic Mimicry and Bevacizumab Resistance by Facilitating FOSL1 Super-enhancer Formation.

Weihao Li, Jianhong Peng, Jiahua He

|Jan 22, 2026
Adjuvant chemo-immunotherapy shows comparable efficacy among mismatch-repair-deficient and mismatch-repair-proficient stage III colon cancer: an exploratory, reconstructed individual patient-level data analysis.

Yu-Tong Chen, Ruowei Wang, Ying-Ting Situ

|Aug 27, 2025
β-elemene promotes ferroptosis to improve the sensitivity of imatinib in gastrointestinal stromal tumours by targeting N6AMT1.

Jin Lan, Weili Zhang, Kaixuan Zeng

|Jul 24, 2025
Short-Term Results of the SONCAR Study: Optimized Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer Patients.

Rongxin Zhang, Fulong Wang, Xinhua Jiang

|Jul 04, 2025
Delayed surgery for more than 9 weeks induces worse survival outcomes in locally advanced rectal cancer patients with poor response to neoadjuvant chemoradiotherapy: a propensity score matched cohort study.

Hao Wang, Yuan Li, Xinyu Ge

Pageof 2

Frequent Collaborators

6 joint publications

Jianhong Peng

3 joint publications

Weihao Li

2 joint publications

Zhenhai Lu

2 joint publications

Xiaojun Wu